FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 2152143 · Received July 7, 2011

Report

Report Number
1423500-2011-08738
Event Type
Injury
Date Received
July 7, 2011
Date of Event
June 1, 2011
Report Date
June 13, 2011
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICES INVOLVED IN THE INCIDENT WERE UNKNOWN. AS THE DATE OF ONSET OF THIS PERITONITIS EPISODE IS UNKNOWN AND PATIENTS DISCARD SUPPLIES AFTER EACH THERAPY, THE SAMPLE WAS NOT REQUESTED. A 510K NUMBER WILL NOT BE PROVIDED IN THE MDR AS THE PRODUCT CODE AND LOT NUMBER ARE UNKNOWN. SINCE THE LOT NUMBER IS UNKNOWN, NO BATCH REVIEW WILL BE PERFORMED. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. THE ROOT CAUSE INVESTIGATION IS IN PROGRESS. THE ROOT CAUSE IS UNDETERMINED.

Description of Event or Problem · 1

THIS IS A SPONTANEOUS REPORT BY A NURSE FROM (B)(6) OF PERITONITIS IN A PATIENT COINCIDENT WITH DIANEAL PD2 ULTRABAG THERAPY. ON AN UNREPORTED DATE, THE PATIENT BEGAN TREATMENT WITH DIANEAL PD2 ULTRABAG THERAPY (DOSE, FREQUENCY AND LOT NUMBERS NOT REPORTED) INTRAPERITONEALLY (IP) FOR PERITONEAL DIALYSIS (PD). ON (B)(6) 2011, THE PATIENT EXPERIENCED PERITONITIS. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. ON (B)(6) 2011, THE PATIENT WAS HOSPITALIZED FOR THE PERITONITIS. REMEDIAL THERAPY CONSISTED OF FORTUM (1 G, TWICE A DAY, IP), AMIKACIN (500 MG, FREQUENCY NOT REPORTED, IP) AND VANCOMYCIN (1 GR, ONCE IN 96 HOURS, IP), ALL ONGOING. THE OUTCOME OF THE PERITONITIS WAS UNKNOWN. THE ACTION TAKEN WITH DIANEAL PD2 ULTRABAG THERAPY WAS NOT REPORTED. CONCOMITANT MEDICATIONS WERE NOT REPORTED. THE NURSE BELIEVED THE PERITONITIS WAS UNRELATED TO DIANEAL PD2 ULTRABAG THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 65 YR Hospitalization| R DIANEAL PD2 ULTRABAG